Skip to content

Clinical trials

Completed Phase 2 Glomerulonephritis, IGA trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20101
20121
20141
20151
20171
20182
20191
20202
20212
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Calliditas Therapeutics AB2
Novartis Pharmaceuticals2
University of Washington2
Amgen1
Apellis Pharmaceuticals, Inc.1
Astellas Pharma Inc1
Biogen1
Chengdu Suncadia Medicine Co., Ltd.1
HI-Bio, A Biogen Company1
Haisco Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA22
Kidney Diseases5
Diabetes Mellitus2
Diabetic Nephropathies2
Glomerulonephritis2
Hypertension2
Hypertension, Renal2
Kidney Failure, Chronic2
Renal Insufficiency, Chronic2
Urologic Diseases2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.